Study of the Safety and Efficacy of an Iontophoretic Device to Treat Recurrent Herpes Labialis

Completed

• Conditions: Recurrent herpes; Infections and Infestations; Herpes labialis

• Registration Number: ISRCTN83097613
• Lead Sponsor: Klearsen Corporation (USA)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2005-09-29
• Last Update Posted: 13 January 2015

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 13

Inclusion Criteria

1. Age 18 years or greater
2. Peri-oral HSV occurring four or more times per year

Exclusion Criteria

1. No serious medical illness
2. No use of systemic immunosuppressive therapy
3. No significant dermatological illness on the face
4. No known allergy to metal ions or components of the electrolyte ointment
5. No antiviral therapy in the 7 days prior to an outbreak and during the outbreak
6. Must forego other treatments for HSV during an outbreak
7. Must forego use of lipstick or other emollients to cover a peri-oral HSV lesion

Study & Design

• Study Type: Interventional
• Study Design: Not specified